Categories:
Scientific Conferences & Meetings,
Heart News
|
Published: November 05, 2022
New medicine reduces triglyceride by 25%, no change in CVD risk in people with Type 2 diabetes
American Heart Association Scientific Sessions 2022, Abstract 17835